Andrew Harkin

6.3k total citations
122 papers, 4.9k citations indexed

About

Andrew Harkin is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Biological Psychiatry. According to data from OpenAlex, Andrew Harkin has authored 122 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cellular and Molecular Neuroscience, 45 papers in Behavioral Neuroscience and 43 papers in Biological Psychiatry. Recurrent topics in Andrew Harkin's work include Stress Responses and Cortisol (45 papers), Tryptophan and brain disorders (43 papers) and Neurotransmitter Receptor Influence on Behavior (32 papers). Andrew Harkin is often cited by papers focused on Stress Responses and Cortisol (45 papers), Tryptophan and brain disorders (43 papers) and Neurotransmitter Receptor Influence on Behavior (32 papers). Andrew Harkin collaborates with scholars based in Ireland, Canada and Germany. Andrew Harkin's co-authors include Thomas J. Connor, John Kelly, Sinead M. Gibney, Brian E. Leonard, Joan B. O’Sullivan, Karen M. Ryan, Ruth McNamara, Ian A. Paul, Neasa Starr and Martina M. Hughes and has published in prestigious journals such as New England Journal of Medicine, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Andrew Harkin

119 papers receiving 4.8k citations

Peers

Countries citing papers authored by Andrew Harkin

Since Specialization

Citations

This map shows the geographic impact of Andrew Harkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Harkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Harkin more than expected).

Fields of papers citing papers by Andrew Harkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Harkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Harkin. The network helps show where Andrew Harkin may publish in the future.

Co-authorship network of co-authors of Andrew Harkin

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Harkin. A scholar is included among the top collaborators of Andrew Harkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Harkin. Andrew Harkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Narrating the psychoneuroimmunomodulatory properties of serotonin 5-HT_2A receptor psychedelics from a transdiagnostic perspective 2025 ·Acta Neuropsychiatrica ·(unknown), Clare Sheridan, (unknown), (unknown), (unknown), (unknown), John R. Kelly, Andrew Harkin	0
2	Essential Oil Constituents as Anti-Inflammatory and Neuroprotective Agents: An Insight through Microglia Modulation 2024 ·International Journal of Molecular Sciences ·Nikola M. Stojanović, (unknown), (unknown), (unknown), (unknown), (unknown), Andrew Harkin, Fábio Boylan	29
3	Insulin and disorders of behavioural flexibility 2023 ·Neuroscience & Biobehavioral Reviews ·(unknown), Fernando Fernández‐Aranda, Lucía Camacho‐Barcia, Andrew Harkin, Simone Macrı̀, Bernat Mora‐Maltas, Susana Jiménez‐Múrcia, Aet O’Leary, (unknown), (unknown), David A. Slattery, Samantha Scholtz, Jeffrey Glennon	6
4	Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin 2023 ·PubMed ·(unknown), (unknown), Barry Moran, Jean M. Fletcher, Andrew Harkin	23
5	Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery 2023 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), Eduardo Ruiz‐Hernández, Andrew Harkin	55
6	Kynurenic Acid Protects Against Reactive Glial-associated Reductions in the Complexity of Primary Cortical Neurons 2021 ·Journal of Neuroimmune Pharmacology ·(unknown), (unknown), Øivind Midttun, (unknown), (unknown), Andrew Harkin	5
7	PBMC telomerase activity in depression and the response to electroconvulsive therapy 2021 ·European Archives of Psychiatry and Clinical Neuroscience ·Karen M. Ryan, (unknown), Andrew Harkin, Declan M. McLoughlin	3
8	Acute neuroinflammation, sickness behavior and working memory responses to acute systemic LPS challenge following noradrenergic lesion in mice 2020 ·Brain Behavior and Immunity ·Eoin O′Neill, Éadaoin W. Griffin, (unknown), Carol Murray, Lucy Ryan, (unknown), Andrew Harkin, Colm Cunningham	24
9	L-alpha-amino adipic acid provokes depression-like behaviour and a stress related increase in dendritic spine density in the pre-limbic cortex and hippocampus in rodents 2019 ·Behavioural Brain Research ·J. David, (unknown), Allison McIntosh, (unknown), (unknown), (unknown), Eleanor T. Coffey, Andrew Harkin	20
10	L‐alpha‐aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson’s disease in male rats 2019 ·Journal of Neuroscience Research ·Eoin O′Neill, (unknown), (unknown), Andrew Harkin	12
11	Treatment with the noradrenaline re-uptake inhibitor atomoxetine alone and in combination with the α2-adrenoceptor antagonist idazoxan attenuates loss of dopamine and associated motor deficits in the LPS inflammatory rat model of Parkinson’s disease 2018 ·Brain Behavior and Immunity ·(unknown), Eoin O′Neill, Yvonne M. Nolan, Thomas J. Connor, Andrew Harkin	26
12	Gut–brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease 2017 ·Acta Neuropsychiatrica ·Áine Abautret-Daly, Elaine Dempsey, Adolfo Parra‐Blanco, Carlos Medina, Andrew Harkin	139
13	Regional specific modulation of neuronal activation associated with nitric oxide synthase inhibitors in an animal model of antidepressant activity 2016 ·Behavioural Brain Research ·Eoin Sherwin, Valentina Gigliucci, Andrew Harkin	12
14	Glial fibrillary acidic protein (GFAP) immunoreactivity correlates with cortical perfusion parameters determined by bolus tracking arterial spin labelling (bt-ASL) magnetic resonance (MR) imaging in the Wistar Kyoto rat 2016 ·Physiology & Behavior ·(unknown), (unknown), Allison McIntosh, Christian Kerskens, Andrew Harkin	14
15	Clenbuterol activates the central IL-1 system via the β2-adrenoceptor without provoking inflammatory response related behaviours in rats 2016 ·Brain Behavior and Immunity ·Karen M. Ryan, Éadaoin W. Griffin, Katie J. Ryan, (unknown), Natacha Vanattou‐Saïfoudine, Eóin N. McNamee, (unknown), (unknown), Andrew Harkin, Thomas J. Connor	7
16	Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders 2015 ·Neuropharmacology ·(unknown), Andrew Harkin	115
17	Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons 2015 ·Neuroscience ·(unknown), Eileen O’Toole, T. Connor, Andrew Harkin	11
18	Expression of glucocorticoid inducible genes is associated with reductions in cornu ammonis and dentate gyrus volumes in patients with major depressive disorder 2014 ·Development and Psychopathology ·Thomas Frodl, Angela Carballedo, (unknown), Veronica O’Keane, Norbert Skokauskas, (unknown), Michael Gill, Martina M. Hughes, Andrew Harkin, Thomas J. Connor	19
19	Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation 2012 ·Brain Behavior and Immunity ·Martina M. Hughes, Angela Carballedo, Declan M. McLoughlin, Francesco Amico, Andrew Harkin, Thomas Frodl, Thomas J. Connor	90
20	Characterization of d-fenfluramine-induced hypothermia: evidence for multiple sites of action 2000 ·European Journal of Pharmacology ·John F. Cryan, Andrew Harkin, Marie Naughton, John Kelly, Brian E. Leonard	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact